[go: up one dir, main page]

WO2008107362A3 - Stabiliser and inhibitors of factor vii - Google Patents

Stabiliser and inhibitors of factor vii Download PDF

Info

Publication number
WO2008107362A3
WO2008107362A3 PCT/EP2008/052409 EP2008052409W WO2008107362A3 WO 2008107362 A3 WO2008107362 A3 WO 2008107362A3 EP 2008052409 W EP2008052409 W EP 2008052409W WO 2008107362 A3 WO2008107362 A3 WO 2008107362A3
Authority
WO
WIPO (PCT)
Prior art keywords
factor vii
inhibitors
stabiliser
blood coagulation
liquid formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/052409
Other languages
French (fr)
Other versions
WO2008107362A2 (en
Inventor
Florencio Zaragoza Doerwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Original Assignee
Novo Nordisk Health Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care AG filed Critical Novo Nordisk Health Care AG
Publication of WO2008107362A2 publication Critical patent/WO2008107362A2/en
Publication of WO2008107362A3 publication Critical patent/WO2008107362A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to novel compounds with formula (I) useful as blood coagulation factor inhibitors. The compounds (I) may be used for treatment of thrombotic conditions or as stabilizers of liquid formulations of blood coagulation factors, in particular liquid formulations of FVIIa, Factor VII variants, or Factor VII derivatives.
PCT/EP2008/052409 2007-03-07 2008-02-28 Stabiliser and inhibitors of factor vii Ceased WO2008107362A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103676 2007-03-07
EP07103676.8 2007-03-07

Publications (2)

Publication Number Publication Date
WO2008107362A2 WO2008107362A2 (en) 2008-09-12
WO2008107362A3 true WO2008107362A3 (en) 2008-10-23

Family

ID=38290139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/052409 Ceased WO2008107362A2 (en) 2007-03-07 2008-02-28 Stabiliser and inhibitors of factor vii

Country Status (1)

Country Link
WO (1) WO2008107362A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2235042A1 (en) * 2008-01-23 2010-10-06 Novo Nordisk Health Care AG New blood coagulation factor inhibitors

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987274A1 (en) * 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
WO2000058346A1 (en) * 1999-03-30 2000-10-05 Sanofi-Synthelabo N-sulfonyl-dipeptide derivatives, production and use thereof in therapy
WO2002026774A2 (en) * 2000-09-27 2002-04-04 The Procter & Gamble Company Melanocortin receptor ligands
WO2004041302A1 (en) * 2002-11-06 2004-05-21 Novo Nordisk A/S Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator
WO2005016365A2 (en) * 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987274A1 (en) * 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Factor VIIa Inhibitors
WO2000058346A1 (en) * 1999-03-30 2000-10-05 Sanofi-Synthelabo N-sulfonyl-dipeptide derivatives, production and use thereof in therapy
WO2002026774A2 (en) * 2000-09-27 2002-04-04 The Procter & Gamble Company Melanocortin receptor ligands
WO2004041302A1 (en) * 2002-11-06 2004-05-21 Novo Nordisk A/S Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator
WO2005016365A2 (en) * 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides

Also Published As

Publication number Publication date
WO2008107362A2 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
WO2007137066A3 (en) HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
WO2008033562A3 (en) Kinase inhibitor compounds
WO2010115491A3 (en) Piperidine and piperazine derivatives as autotaxin inhibitors
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
WO2009155001A3 (en) Wnt protein signalling inhibitors
WO2011159839A3 (en) Thioacetate compounds, compositions and methods of use
WO2009070740A3 (en) Novel compounds and compositions and methods of use
WO2007101864A3 (en) Compounds that modulate ppar activity, their preparation and use
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2008073933A3 (en) 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
WO2010074588A8 (en) Pharmaceutical compounds
WO2011159840A3 (en) Phenylthioacetate compounds, compositions and methods of use
WO2007097931A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007136603A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
WO2010028189A3 (en) Compounds, compositions and methods of using same for modulating uric acid levels
AU2010230585A8 (en) Autotaxin inhibitors
WO2010135530A3 (en) Compounds, compositions and methods for modulating uric acid levels
WO2007095601A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2007125103A3 (en) Benzamide glucokinase activators
WO2009051244A1 (en) Heterocyclic compound
WO2009077471A3 (en) Azolylmethyloxiranes, use thereof and agents containing the same
MX2009010960A (en) Heterocyclic compounds and their methods of use.
WO2010062927A3 (en) Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers
WO2007125105A3 (en) Benzamide glucokinase activators

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08717207

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08717207

Country of ref document: EP

Kind code of ref document: A2